FI933507A - Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning - Google Patents

Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI933507A
FI933507A FI933507A FI933507A FI933507A FI 933507 A FI933507 A FI 933507A FI 933507 A FI933507 A FI 933507A FI 933507 A FI933507 A FI 933507A FI 933507 A FI933507 A FI 933507A
Authority
FI
Finland
Prior art keywords
conjugates
complexes
preparation
contrast agents
bicyclopolyazamacrocyclophosphonic
Prior art date
Application number
FI933507A
Other languages
English (en)
Finnish (fi)
Other versions
FI933507A0 (fi
Inventor
Garry E Kiefer
Jaime Simon
Joseph R Garlich
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of FI933507A0 publication Critical patent/FI933507A0/fi
Publication of FI933507A publication Critical patent/FI933507A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI933507A 1993-05-06 1993-08-09 Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning FI933507A (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/004325 WO1994026754A1 (en) 1993-05-06 1993-05-06 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation

Publications (2)

Publication Number Publication Date
FI933507A0 FI933507A0 (fi) 1993-08-09
FI933507A true FI933507A (sv) 1994-11-07

Family

ID=22236574

Family Applications (2)

Application Number Title Priority Date Filing Date
FI933507A FI933507A (sv) 1993-05-06 1993-08-09 Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning
FI955335A FI955335A0 (fi) 1993-05-06 1995-11-06 Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI955335A FI955335A0 (fi) 1993-05-06 1995-11-06 Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa

Country Status (8)

Country Link
EP (1) EP0696290A1 (sv)
JP (1) JPH08509976A (sv)
KR (2) KR960702470A (sv)
AU (1) AU665689B2 (sv)
FI (2) FI933507A (sv)
NO (2) NO304985B1 (sv)
NZ (1) NZ252554A (sv)
WO (1) WO1994026754A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207826B1 (en) 1995-03-27 2001-03-27 Isis Pharmaceuticals, Inc. Macrocyclic compounds having nitrogen-containing linkages
EP0817787A4 (en) * 1995-03-27 2000-09-13 Isis Pharmaceuticals Inc NITROGEN MACROCYCLIC COMPOUNDS
EP0898574B1 (en) * 1996-04-19 2003-11-12 Dow Global Technologies Inc. Fluorescent chelates as visual tissue specific imaging agents
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
CN106518896A (zh) * 2016-10-27 2017-03-22 南京大学 锌‑四氮环配合物及其制备方法和在抗肿瘤药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636632B1 (fr) * 1988-09-16 1996-02-02 Oris Ind Produits radiopharmaceutiques constitues par des complexes de tc, re ou y comportant des ligands tetraphosphonates et leur preparation
FR2644785B1 (fr) * 1989-03-24 1991-07-05 Guerbet Sa Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
WO1991010669A1 (en) * 1990-01-19 1991-07-25 Cockbain, Julian, Roderick, Michaelson Chelating compounds
WO1993011802A1 (en) * 1991-12-10 1993-06-24 The Dow Chemical Company Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation

Also Published As

Publication number Publication date
NO932823D0 (no) 1993-08-09
AU665689B2 (en) 1996-01-11
WO1994026754A1 (en) 1994-11-24
NZ252554A (en) 1998-01-26
KR950700916A (ko) 1995-02-20
NO304985B1 (no) 1999-03-15
FI933507A0 (fi) 1993-08-09
NO954442D0 (no) 1995-11-06
KR960702470A (ko) 1996-04-27
FI955335A0 (fi) 1995-11-06
AU4238293A (en) 1994-12-12
NO932823L (no) 1993-10-08
JPH08509976A (ja) 1996-10-22
EP0696290A1 (en) 1996-02-14
NO954442L (no) 1996-01-05

Similar Documents

Publication Publication Date Title
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE9700039A (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
FI941137A (sv) 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa
CY2013003I1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE03878B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks
EE200000129A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI960316A (sv) Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma
FI961378A0 (sv) Förfarande för framställning av N-metyl-3-(1-metyl-4-piperidinyl)-14-indol-5-etansulfonamid
FI933507A (sv) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning
BR9507768A (pt) Composição farmacêutica
FI953956A0 (sv) 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel
FI102169B (sv) 3-aminopyrroler, förfaranden för deras framställning, och deras använd ning som läkemedel
FI941912A0 (sv) 3-kinolylsubstituerade dihydropyridiner, förfarande för framställning av dessa samt använding av dessa i läkemedel
FI933506A (sv) Bicyklopolyazamakrocyklokarboxylsyrakomplex, konjugat daerav, foerfarande foer deras framstaellning och anvaendning som kontrastmedel
FI970696A (sv) Oligonukleotidkonjugat, sammansättningar och förfaranden för spjälkning av ribonukleinsyror
BR9402493A (pt) Composição de micro-emulsão ácida
HU9503189D0 (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and process their preparation
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
KR930703331A (ko) 비사이클로폴리아자매크로사이클로카복실산 착체, 그의 결합체, 그의 제조방법 및 방사성 약제로서의 그의 용도